Sartorius | SRT3 - Gross Profit On Sales

Stock Price
239.70
Daily Change
-2.10 -0.87%
Monthly
-9.55%
Yearly
-4.96%
Q1 Forecast
228.84

Sartorius reported EUR393.2M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.95M 1.18M Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Moderna USD 809M 791M Sep/2025
Organon & Co USD 857M 17M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Sartorius EUR 393.2M 23M Sep/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.37B 38.6M Sep/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025